JFNAX
Price
$63.09
Change
-$0.44 (-0.69%)
Updated
May 8 closing price
Net Assets
4.66B
PRHSX
Price
$75.04
Change
-$0.76 (-1.00%)
Updated
May 8 closing price
Net Assets
11.48B
Ad is loading...

JFNAX vs PRHSX

Header iconJFNAX vs PRHSX Comparison
Open Charts JFNAX vs PRHSXBanner chart's image
Janus Henderson Global Life Sciences A
Price$63.09
Change-$0.44 (-0.69%)
VolumeN/A
Net Assets4.66B
T. Rowe Price Health Sciences
Price$75.04
Change-$0.76 (-1.00%)
VolumeN/A
Net Assets11.48B
JFNAX vs PRHSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNAX vs. PRHSX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNAX is a Buy and PRHSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 11.5B vs. JFNAX (4.66B). JFNAX pays higher dividends than PRHSX: JFNAX (0.13) vs PRHSX (0.01). JFNAX was incepted earlier than PRHSX: JFNAX (16 years) vs PRHSX (29 years). JFNAX (0.98) is less costly to investors than PRHSX (0.80). PRHSX is a more actively managed with annual turnover of: 52.40 vs. JFNAX (35.00). JFNAX (2500) and PRHSX (2500) have matching initial minimum investment requirements. JFNAX annual gain was more profitable for investors over the last year : -11.41 vs. PRHSX (-18.57). JFNAX return over 5 years is better than : 9.96 vs. PRHSX (-8.09).
JFNAXPRHSXJFNAX / PRHSX
Total Expense Ratio0.980.80122%
Annual Report Gross Expense Ratio0.980.80122%
Fund Existence16 years29 years-
Gain YTD-4.106-4.99282%
Front Load6%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B11.5B40%
Annual Yield % from dividends0.130.011,438%
Returns for 1 year-11.41-18.5761%
Returns for 3 years9.19-11.35-81%
Returns for 5 years9.96-8.09-123%
Returns for 10 years9.08-3.07-295%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQSCX22.78N/A
N/A
Virtus KAR Small-Cap Value C
SGTTX67.39N/A
N/A
Columbia Seligman Global Tech Inst2
AKRSX70.64N/A
N/A
Akre Focus Supra Institutional
LOGSX20.26N/A
N/A
Live Oak Health Sciences
SEECX32.85N/A
N/A
Steward Values Enhanced Lg Cap I